Quarterly Results

VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE328.00-2 (-0.61 %)
PREV CLOSE ( ) 330.00
OPEN PRICE ( ) 330.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2847
TODAY'S LOW / HIGH ( )327.40 333.75
52 WK LOW / HIGH ( )185.65 429.6
NSE328.20-1.5 (-0.45 %)
PREV CLOSE( ) 329.70
OPEN PRICE ( ) 328.45
BID PRICE (QTY) 328.20 (286)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18520
TODAY'S LOW / HIGH( ) 327.75 334.65
52 WK LOW / HIGH ( )188.6 430
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1434.2
1677.2
951.5
1556.4
Total Expenditure
1313.8
1499.3
847.5
1310.3
PBIDT (Excl OI)
120.4
177.9
104
246.1
Other Income
23.5
30.5
22.6
34.1
Operating Profit
143.9
208.4
126.6
280.2
Interest
0.7
0.6
0.6
NA
Exceptional Items
NA
NA
NA
NA
PBDT
143.2
207.8
126
280.2
Depreciation
65.4
64.4
75.5
82.9
Profit Before Tax
77.79
143.4
50.50
197.3
Tax
9.3
44
38.7
86.7
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
68.49
99.40
11.80
110.6
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
68.49
99.40
11.80
110.6
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
68.5
99.4
11.8
110.6
Equity Capital
133.7
133.7
133.7
133.7
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
5.12
7.43
0.88
8.27
Calculated EPS (Annualised)
20.49
29.73
3.53
33.08
No of Public Share Holdings
7784991
7784991
7784992
7784992
% of Public Share Holdings
58.24
58.24
58.24
58.24
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
8.39
10.60
10.93
15.81
PBIDTM%
10.03
12.42
13.30
18.00
PBDTM%
9.98
12.38
13.24
18.00
PBTM%
5.42
8.54
5.30
12.67
PATM%
4.77
5.92
1.24
7.10
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.